Surgical Staplers Market

Executive Summary

Surgical Staplers Market was valued at US $4.22 billion in 2021 and is projected to grow at 8.28% CAGR over the forecast period to reach US $6.81 billion by 2027. Surgical Staplers Market represented US $0.62 billion opportunity over 2019-2021 and estimated to create US $2.59 billion opportunity in 2027 over 2021.

Surgical Staplers from Consainsights analyses the Surgical Staplers Market in the Life Sciences industry over the forecast period to 2027.

Surgical Staplers research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Surgical Staplers segmentation includes Product, Type, End User, Application, Region and Geography.

Based on the Product, the Surgical Staplers analysis covers Manual Surgical Staplers, Powered Surgical Staplers.

In Product segment, Manual Surgical Staplers segment has highest cagr growth of 7.33%.

Based on the Type, the Surgical Staplers analysis covers Disposable Surgical Staplers, Reusable Surgical Staplers.

In Type segment, Disposable Surgical Staplers segment has highest cagr growth of 7.33%.

Based on the End User, the Surgical Staplers analysis covers Hospitals, Ambulatory Surgical Centers (Ascs) & Clinics.

In End User segment, Hospitals segment has highest cagr growth of 7.33%.

Based on the Application, the Surgical Staplers analysis covers Abdominal & Pelvic Surgery, General Surgery, Cardiac And Thoracic Surgery, Orthopedic Surgery, Other Surgical Applications.

In Application segment, Abdominal & Pelvic Surgery segment has highest cagr growth of 7.33%.

Based on the Region, the Surgical Staplers analysis covers North America, Europe, Asia-Pacific (Apac), Rest of the World.

In Region segment, North America segment has highest cagr growth of 7.33%.

Based on the region, the Surgical Staplers analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Ethicon Inc. (A Subsidiary of Johnson & Johnson), Medtronic Plc, Intuitive Surgical Inc., Dextera Surgical Inc., Conmed Corporation, Smith & Nephew, Becton, Dickinson And Company, Company, B. Braun Melsungen Ag, Purple Surgical, Frankenman International Ltd., Welfare Medical Ltd., Reach Surgical, Grena Ltd., Meril Life Sciences Pvt Ltd. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Manual Surgical Staplers segment has the highest revenue of US $3.24 billion and is expected to grow at CAGR of 7.33% by 2027 Manual Surgical Staplers segment has highest cagr growth of 7.33%.

Manual Surgical Staplers

Manual Surgical Staplers segment was valued at US $2.76 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $5.22 billion by 2027. Manual Surgical Staplers segment represented US $0.48 billion opportunity over 2019-2021 and estimated to create US $1.98 billion opportunity in 2027 over 2021.

Powered Surgical Staplers

Powered Surgical Staplers segment was valued at US $0.84 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $1.59 billion by 2027. Powered Surgical Staplers segment represented US $0.15 billion opportunity over 2019-2021 and estimated to create US $0.60 billion opportunity in 2027 over 2021.

Type

Introduction

In 2021, Disposable Surgical Staplers segment has the highest revenue of US $2.75 billion and is expected to grow at CAGR of 7.33% by 2027 Disposable Surgical Staplers segment has highest cagr growth of 7.33%.

Disposable Surgical Staplers

Disposable Surgical Staplers segment was valued at US $2.35 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $4.43 billion by 2027. Disposable Surgical Staplers segment represented US $0.40 billion opportunity over 2019-2021 and estimated to create US $1.68 billion opportunity in 2027 over 2021.

Reusable Surgical Staplers

Reusable Surgical Staplers segment was valued at US $1.26 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $2.37 billion by 2027. Reusable Surgical Staplers segment represented US $0.22 billion opportunity over 2019-2021 and estimated to create US $0.90 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $3.15 billion and is expected to grow at CAGR of 7.33% by 2027 Hospitals segment has highest cagr growth of 7.33%.

Hospitals

Hospitals segment was valued at US $2.69 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $5.08 billion by 2027. Hospitals segment represented US $0.46 billion opportunity over 2019-2021 and estimated to create US $1.93 billion opportunity in 2027 over 2021.

Ambulatory Surgical Centers (Ascs) & Clinics

Ambulatory Surgical Centers (Ascs) & Clinics segment was valued at US $0.91 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $1.73 billion by 2027. Ambulatory Surgical Centers (Ascs) & Clinics segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.66 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Abdominal & Pelvic Surgery segment has the highest revenue of US $1.77 billion and is expected to grow at CAGR of 7.33% by 2027 Abdominal & Pelvic Surgery segment has highest cagr growth of 7.33%.

Abdominal & Pelvic Surgery

Abdominal & Pelvic Surgery segment was valued at US $1.51 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $2.85 billion by 2027. Abdominal & Pelvic Surgery segment represented US $0.26 billion opportunity over 2019-2021 and estimated to create US $1.08 billion opportunity in 2027 over 2021.

General Surgery

General Surgery segment was valued at US $0.80 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $1.51 billion by 2027. General Surgery segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.57 billion opportunity in 2027 over 2021.

Cardiac And Thoracic Surgery

Cardiac And Thoracic Surgery segment was valued at US $0.72 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $1.37 billion by 2027. Cardiac And Thoracic Surgery segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.52 billion opportunity in 2027 over 2021.

Orthopedic Surgery

Orthopedic Surgery segment was valued at US $0.56 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $1.05 billion by 2027. Orthopedic Surgery segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.40 billion opportunity in 2027 over 2021.

Other Surgical Applications

Other Surgical Applications segment was valued at US $0.02 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $0.03 billion by 2027. Other Surgical Applications segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.01 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $2.03 billion and is expected to grow at CAGR of 7.33% by 2027 North America segment has highest cagr growth of 7.33%.

North America

North America segment was valued at US $1.73 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $3.27 billion by 2027. North America segment represented US $0.30 billion opportunity over 2019-2021 and estimated to create US $1.24 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $0.96 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $1.81 billion by 2027. Europe segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.69 billion opportunity in 2027 over 2021.

Asia-Pacific (Apac)

Asia-Pacific (Apac) segment was valued at US $0.57 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $1.07 billion by 2027. Asia-Pacific (Apac) segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.41 billion opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $0.35 billion in 2019 and is projected to grow at 7.33% CAGR over the forecast period to reach US $0.66 billion by 2027. Rest of the World segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.25 billion opportunity in 2027 over 2021.